{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T02:15:13Z","timestamp":1788401713077,"version":"build-2803163510"},"reference-count":52,"publisher":"American Chemical Society (ACS)","issue":"11","license":[{"start":{"date-parts":[[2016,9,29]],"date-time":"2016-09-29T00:00:00Z","timestamp":1475107200000},"content-version":"vor","delay-in-days":14,"URL":"https:\/\/pubs.acs.org\/page\/policy\/authorchoice_termsofuse.html"}],"funder":[{"DOI":"10.13039\/501100001427","name":"All India Council for Technical Education","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100001427","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,11,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Vesicular and colloidal delivery systems can be designed to control drug release spatially and temporally to improve drug efficacy and side effect profiles. Niosomes (vesicles prepared from nonionic surfactants in aqueous media) are gaining interest as an alternative vesicular delivery system as they offer advantages such as biocompatibility, chemical stability, low cost, high purity, and versatility. However, the physical stability of niosomes, like other vesicular systems, is limited by vesicle fusion, aggregation, and leakage. Proniosomes (dehydrated powder or gel formulations that spontaneously form niosomes on hydration with aqueous media) can overcome these physical stability problems and are more convenient for sterilization, storage, transport, distribution, and dosing. Proniosomes have mostly been explored for their potential to enhance transdermal and oral absorption. In this study we assess, for the first time, the potential for hydrated proniosomes to sustain systemic exposure and therapeutic effect after intravenous delivery. Proniosomes carrying the anti-inflammatory drug, flurbiprofen, were prepared by spraying different nonionic surfactants (span 20, span 40, and span 60 in varying ratios with span 80) and cholesterol onto a sorbitol carrier. The proniosome powders were characterized for surface morphology and flow properties. Niosome formation was assessed at three different hydration temperatures (25, 37, and 45 \u00b0C), and the niosomes were assessed for vesicle size, entrapment efficiency, and sterility. OLP proniosomes prepared with a high ratio of span 80 to span 20 were found to spontaneously form vesicles of small size and high drug loading on hydration with aqueous media. The OLP derived niosomes successfully sustained in vitro drug release, in vivo pharmacokinetics, and the anti-inflammatory effect of flurbiprofen in an acute (rat paw edema) model of inflammation when compared to a control solution formulation. The study demonstrates that hydrated proniosomes can prolong systemic drug exposure over 3 days and provide a sustained therapeutic effect. The developed proniosomes represent a novel approach to treat acute pain and inflammation with the potential to be administered as a single intravenous dose by a clinician at the time of injury or surgery that provides adequate relief for several days and reduces fluctuations in therapy. Similar systems loaded with different drugs have potential for broader application in anesthesia, anti-infective, antiemetic, and cancer therapy.<\/jats:p>","DOI":"10.1021\/acs.molpharmaceut.6b00504","type":"journal-article","created":{"date-parts":[[2016,9,15]],"date-time":"2016-09-15T14:26:21Z","timestamp":1473949581000},"page":"3688-3699","source":"Crossref","is-referenced-by-count":30,"title":["Single Intravenous Dose of Novel Flurbiprofen-Loaded\nProniosome Formulations Provides Prolonged Systemic Exposure and Anti-inflammatory\nEffect"],"prefix":"10.1021","volume":"13","author":[{"given":"Preeti","family":"Verma","sequence":"first","affiliation":[{"name":"Monash University , , , ,","place":["Parkville, VIC, Australia, 3052"]},{"name":"Bundelkhand University , , - , ,","place":["Jhansi, Uttar Pradesh, India, 284001"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil K.","family":"Prajapati","sequence":"additional","affiliation":[{"name":"Bundelkhand University , , - , ,","place":["Jhansi, Uttar Pradesh, India, 284001"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajbharan","family":"Yadav","sequence":"additional","affiliation":[{"name":"Monash University , , , ,","place":["Parkville, VIC, Australia, 3052"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Senyschyn","sequence":"additional","affiliation":[{"name":"Monash University , , , ,","place":["Parkville, VIC, Australia, 3052"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter R.","family":"Shea","sequence":"additional","affiliation":[{"name":"Anaesthetic Group Ballarat , 6 Drummond Street , , ,","place":["North Ballarat, VIC, Australia, 3350"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie L.","family":"Trevaskis","sequence":"additional","affiliation":[{"name":"Monash University , , , ,","place":["Parkville, VIC, Australia, 3052"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2016,9,15]]},"reference":[{"issue":"2","key":"2026090221460162500_cit1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3109\/10717544.2013.838077","article-title":"Recent advances in non-ionic surfactant\nvesicles (niosomes): self-assembly, fabrication, characterization,\ndrug delivery applications and limitations","volume":"21","author":"Abdelkader","year":"2014","journal-title":"Drug Delivery"},{"issue":"4","key":"2026090221460162500_cit2","doi-asserted-by":"publisher","first-page":"344","DOI":"10.2174\/1389201016666150206101443","article-title":"Provesicles as novel drug delivery\nsystems","volume":"16","author":"Bayindir","year":"2015","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"2","key":"2026090221460162500_cit3","doi-asserted-by":"publisher","first-page":"42","DOI":"10.4103\/0976-0105.113609","article-title":"A review on\nproniosomal drug delivery\nsystem for targeted drug action","volume":"4","author":"Radha","year":"2013","journal-title":"J. Basic Clin\nPharm."},{"issue":"4","key":"2026090221460162500_cit4","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3109\/10717544.2013.841783","article-title":"A review on\nnovel vesicular drug delivery: proniosomes","volume":"21","author":"Yasam","year":"2014","journal-title":"Drug Delivery"},{"issue":"2","key":"2026090221460162500_cit5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0378-5173(97)00135-X","article-title":"Liposomes in drug delivery: progress\nand limitations","volume":"154","author":"Sharma","year":"1997","journal-title":"Int. J. Pharm."},{"issue":"4","key":"2026090221460162500_cit6","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/j.2042-7158.1985.tb05051.x","article-title":"The effect of non-ionic surfactant vesicle (niosome)\nentrapment on the absorption and distribution of methotrexate in mice","volume":"37","author":"Azmin","year":"1985","journal-title":"J. Pharm. Pharmacol."},{"issue":"12","key":"2026090221460162500_cit7","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/j.2042-7158.1985.tb04990.x","article-title":"The preparation\nand properties of niosomes--non-ionic surfactant vesicles","volume":"37","author":"Baillie","year":"1985","journal-title":"J. Pharm. Pharmacol."},{"issue":"6","key":"2026090221460162500_cit8","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1080\/026520499288672","article-title":"Niosomal delivery\nof 5-fluorouracil","volume":"16","author":"Namdeo","year":"1999","journal-title":"J. Microencapsulation"},{"issue":"4","key":"2026090221460162500_cit9","doi-asserted-by":"publisher","first-page":"374","DOI":"10.4103\/0110-5558.76435","article-title":"Niosome: A future of targeted drug\ndelivery systems","volume":"1","author":"Kuotsu","year":"2010","journal-title":"J. Adv. Pharm. Technol. Res."},{"key":"2026090221460162500_cit10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/10837450.2015.1135344","article-title":"Technology overview and drug delivery\napplication of proniosome","author":"Ahmad","year":"2016","journal-title":"Pharm. Dev. Technol."},{"issue":"1","key":"2026090221460162500_cit11","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1208\/ps030101","article-title":"Maltodextrin-based\nproniosomes","volume":"3","author":"Blazek-Welsh","year":"2001","journal-title":"AAPS PharmSci"},{"issue":"5","key":"2026090221460162500_cit12","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1023\/A:1011037527889","article-title":"SEM imaging predicts\nquality of niosomes from maltodextrin-based\nproniosomes","volume":"18","author":"Blazek-Welsh","year":"2001","journal-title":"Pharm. Res."},{"issue":"1\u20132","key":"2026090221460162500_cit13","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0378-5173(00)00513-5","article-title":"Proniosomes: a novel\ndrug carrier preparation","volume":"206","author":"Hu","year":"2000","journal-title":"Int. J. Pharm."},{"key":"2026090221460162500_cit14","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.ijbiomac.2014.05.075","article-title":"Maltodextrin\nbased\nproniosomes of nateglinide: bioavailability assessment","volume":"69","author":"Sahoo","year":"2014","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"2026090221460162500_cit15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1080\/10717540490265243","article-title":"The effect of different\nlipid components on the in vitro stability\nand release kinetics of liposome formulations","volume":"11","author":"Anderson","year":"2004","journal-title":"Drug Delivery"},{"issue":"6","key":"2026090221460162500_cit16","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3109\/13880209.2010.528432","article-title":"Transdermal absorption enhancement\nof gel containing\nelastic niosomes loaded with gallic acid from Terminalia chebula galls","volume":"49","author":"Manosroi","year":"2011","journal-title":"Pharm. Biol."},{"issue":"1\u20132","key":"2026090221460162500_cit17","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.ijpharm.2007.11.037","article-title":"Innovative bola-surfactant\nniosomes as topical delivery\nsystems of 5-fluorouracil for the treatment of skin cancer","volume":"353","author":"Paolino","year":"2008","journal-title":"Int. J. Pharm."},{"issue":"9","key":"2026090221460162500_cit18","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1002\/jps.20491","article-title":"Stealth PEG-PHDCA\nniosomes: effects\nof chain length of PEG and particle size on niosomes surface properties,\nin vitro drug release, phagocytic uptake, in vivo pharmacokinetics\nand antitumor activity","volume":"95","author":"Shi","year":"2006","journal-title":"J. Pharm. Sci."},{"issue":"ss05","key":"2026090221460162500_cit19","first-page":"1","article-title":"Malaria Surveillance-United\nStates, 2011. Center for Disease Control and Prevention","volume":"62","author":"Cullen","year":"2013","journal-title":"Morbidity and Mortality Weekly Report (MMWR)"},{"key":"2026090221460162500_cit20","first-page":"869","article-title":"Anti inflammatory and analgesic actions\nand skin irritation of flurbiprofen by dermal application","volume":"13","author":"Kitagawa","year":"1993","journal-title":"Lyakuhin Kenkyu"},{"key":"2026090221460162500_cit21","first-page":"293","article-title":"Anti-inflammatory\neffect of flurbiprofen for dermal application (FP-A)","volume":"15","author":"Kyuki","year":"1984","journal-title":"Iyakuhin Kenkyu"},{"key":"2026090221460162500_cit22","first-page":"878","article-title":"Anti-inflammatory\neffect of flurbiprofen by topical application","volume":"13","author":"Masumoto","year":"1982","journal-title":"Iyakuhin Kenkyu"},{"key":"2026090221460162500_cit23","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.2147\/IJN.S67343","article-title":"Sulfatide-containing\nlipid perfluorooctylbromide nanoparticles as paclitaxel vehicles targeting\nbreast carcinoma","volume":"9","author":"Li","year":"2014","journal-title":"Int. J. Nanomed."},{"issue":"1\u20132","key":"2026090221460162500_cit24","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0378-5173(01)00721-9","article-title":"Filter extrusion\nof liposomes using different devices: comparison of liposome size,\nencapsulation efficiency, and process characteristics","volume":"223","author":"Berger","year":"2001","journal-title":"Int. J. Pharm."},{"issue":"4","key":"2026090221460162500_cit25","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1021\/mp0700110","article-title":"Proniosomal\npowder of captopril: formulation and evaluation","volume":"4","author":"Gupta","year":"2007","journal-title":"Mol. Pharmaceutics"},{"issue":"1","key":"2026090221460162500_cit26","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0378-5173(99)00265-3","article-title":"Preparation and evaluation of liposomal\nformulations of tropicamide for ocular delivery","volume":"190","author":"Nagarsenker","year":"1999","journal-title":"Int. J. Pharm."},{"issue":"1","key":"2026090221460162500_cit27","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1208\/s12249-012-9751-1","article-title":"Transdermal\nabsorption enhancement of rice bran bioactive compounds entrapped\nin niosomes","volume":"13","author":"Manosroi","year":"2012","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"2026090221460162500_cit28","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.nano.2011.05.013","article-title":"A comparison of\nchanges to doxorubicin pharmacokinetics, antitumor activity, and toxicity\nmediated by PEGylated dendrimer and PEGylated liposome drug delivery\nsystems","volume":"8","author":"Kaminskas","year":"2012","journal-title":"Nanomedicine"},{"issue":"4","key":"2026090221460162500_cit29","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1023\/A:1018987120738","article-title":"A novel assay to\ndetermine the hemolytic activity of\ndrugs incorporated in colloidal carrier systems","volume":"11","author":"Bock","year":"1994","journal-title":"Pharm. Res."},{"issue":"97","key":"2026090221460162500_cit30","doi-asserted-by":"publisher","first-page":"45389","DOI":"10.3791\/52389","article-title":"The mesenteric lymph\nduct cannulated rat model: application to the assessment of intestinal\nlymphatic drug transport","author":"Trevaskis","year":"2015","journal-title":"J. Visualized Exp."},{"issue":"5","key":"2026090221460162500_cit31","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/BF02353864","article-title":"Comparison\nof the Akaike Information\nCriterion, the Schwarz criterion and the F test as guides to model\nselection","volume":"22","author":"Ludden","year":"1994","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"2026090221460162500_cit32","doi-asserted-by":"publisher","first-page":"S76","DOI":"10.3233\/JRS-150697","article-title":"Rat paw oedema modeling and NSAIDs:\nTiming of effects","volume":"27","author":"Cong","year":"2015","journal-title":"Int. J. Risk Saf Med."},{"issue":"2","key":"2026090221460162500_cit33","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/sj.bjp.0705650","article-title":"Carrageenan-induced\nmouse paw oedema\nis biphasic, age-weight dependent and displays differential nitric\noxide cyclooxygenase-2 expression","volume":"142","author":"Posadas","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"2026090221460162500_cit34","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1476-511X-8-6","article-title":"Lipid nanoparticles for transdermal delivery of flurbiprofen:\nformulation, in vitro, ex vivo and in vivo studies","volume":"8","author":"Bhaskar","year":"2009","journal-title":"Lipids Health Dis."},{"key":"2026090221460162500_cit35","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1385\/1-59259-374-7:115","article-title":"Carrageenan-induced\npaw edema in the rat and mouse","volume":"225","author":"Morris","year":"2003","journal-title":"Methods Mol.\nBiol."},{"issue":"5","key":"2026090221460162500_cit36","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3109\/02652049509006779","article-title":"Enhanced in vivo performance of liposomal\nindomethacin derived from effervescent granule based proliposomes","volume":"12","author":"Katare","year":"1995","journal-title":"J. Microencapsulation"},{"issue":"5","key":"2026090221460162500_cit37","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1159\/000086666","article-title":"Liposomes and niosomes\nas topical drug delivery systems","volume":"18","author":"Choi","year":"2005","journal-title":"Skin Pharmacol\nPhysiol"},{"issue":"20","key":"2026090221460162500_cit38","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.2174\/1381612821666150428145940","article-title":"Proniosomes in transdermal drug delivery","volume":"21","author":"Rahimpour","year":"2015","journal-title":"Curr. Pharm. Des."},{"issue":"9","key":"2026090221460162500_cit39","doi-asserted-by":"publisher","first-page":"671","DOI":"10.3109\/10611860903079454","article-title":"Niosomes in\nsustained and targeted\ndrug delivery: some recent advances","volume":"17","author":"Azeem","year":"2009","journal-title":"J. Drug\nTarget"},{"key":"2026090221460162500_cit40","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/B978-044482917-7\/50032-6","article-title":"Strategies\nfor large scale production and optimized stability of pharmaceutical\nliposomes developed for parenteral use","volume-title":"Medical Applications of Liposomes","author":"Winden","year":"1998"},{"issue":"1\u20132","key":"2026090221460162500_cit41","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0378-5173(02)00301-0","article-title":"Studies on\na high encapsulation of colchicine by a niosome system","volume":"244","author":"Hao","year":"2002","journal-title":"Int. J. Pharm."},{"issue":"1\u20132","key":"2026090221460162500_cit42","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ijpharm.2008.05.031","article-title":"Effect of some formulation\nparameters on flurbiprofen encapsulation and release rates of niosomes\nprepared from proniosomes","volume":"361","author":"Mokhtar","year":"2008","journal-title":"Int. J. Pharm."},{"issue":"1","key":"2026090221460162500_cit43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0378-5173(94)90228-3","article-title":"Preparation and properties\nof vesicles\n(niosomes) of sorbitan monoesters (Span 20, 40, 60 and 80) and a sorbitan\ntriester (Span 85)","volume":"105","author":"Yoshioka","year":"1994","journal-title":"Int. J. Pharm."},{"key":"2026090221460162500_cit44","first-page":"82","article-title":"Studies on surface\nfilm of sorbitan esters at the air\/water\ninterface","volume":"9","author":"Wan","year":"1974","journal-title":"Can. J. Pharm. Sci."},{"issue":"1","key":"2026090221460162500_cit45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0001-8686(95)00242-I","article-title":"Nonionic Surfactant\nVesicles (Niosomes) - Physical\nand Pharmaceutical Chemistry","volume":"58","author":"Uchegbu","year":"1995","journal-title":"Adv. Colloid Interface\nSci."},{"issue":"8","key":"2026090221460162500_cit46","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1002\/jps.2600770805","article-title":"Stereoselective\npharmacokinetics of flurbiprofen in humans and rats","volume":"77","author":"Jamali","year":"1988","journal-title":"J. Pharm. Sci."},{"issue":"6","key":"2026090221460162500_cit47","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.3906\/sag-1408-129","article-title":"Paclitaxel-loaded\nniosomes for intravenous\nadministration: pharmacokinetics and tissue distribution in rats","volume":"45","author":"Bayindir","year":"2015","journal-title":"Turk. J. Med. Sci."},{"issue":"1\u20132","key":"2026090221460162500_cit48","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ijpharm.2008.03.047","article-title":"Comparative pharmacokinetics\nof breviscapine liposomes in dogs, rabbits and rats","volume":"359","author":"Lv","year":"2008","journal-title":"Int. J. Pharm."},{"issue":"9","key":"2026090221460162500_cit49","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.tibtech.2012.04.008","article-title":"Colloidal systems\nfor drug delivery: from design to therapy","volume":"30","author":"Beija","year":"2012","journal-title":"Trends\nBiotechnol."},{"key":"2026090221460162500_cit50","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.2147\/IJN.S47129","article-title":"Nanomedicine\nfor drug targeting: strategies beyond the enhanced permeability and\nretention effect","volume":"9","author":"Nehoff","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"2026090221460162500_cit51","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3389\/fphar.2015.00286","article-title":"Advances and Challenges\nof Liposome Assisted Drug Delivery","volume":"6","author":"Sercombe","year":"2015","journal-title":"Front. Pharmacol."},{"issue":"3","key":"2026090221460162500_cit52","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1007\/s00167-012-2095-2","article-title":"The effect of nonsteroidal\nanti-inflammatory drugs\non tissue healing","volume":"21","author":"Chen","year":"2013","journal-title":"Knee Surg Sports Traumatol\nArthrosc"}],"container-title":["Molecular Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.6b00504","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article-pdf\/13\/11\/3688\/67090689\/acs.molpharmaceut.6b00504.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article-pdf\/13\/11\/3688\/67090689\/acs.molpharmaceut.6b00504.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T01:49:22Z","timestamp":1788400162000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article\/13\/11\/3688\/1678006\/Single-Intravenous-Dose-of-Novel-Flurbiprofen"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,15]]},"references-count":52,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2016,9,15]]},"published-print":{"date-parts":[[2016,11,7]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.6b00504","relation":{},"ISSN":["1543-8384","1543-8392"],"issn-type":[{"value":"1543-8384","type":"print"},{"value":"1543-8392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,15]]}}}